Ovagen (20 mg Vial) Dosage Protocol
Quickstart Highlights
Ovagen is a synthetic ultrashort tripeptide (Glu-Asp-Leu; EDL) studied as a bioregulator of gastrointestinal and liver tissues[1]. In vitro studies demonstrate that EDL increases cell proliferation and modulates aging-related gene markers (p16, p21, p53, SIRT-6) in renal cell cultures[2]. No controlled human trials exist; available data are preclinical and cell-based. This educational protocol presents a once-daily subcutaneous approach with gradual titration using microgram-level dosing.
Dosing & Reconstitution Guide
Educational guide for reconstitution and daily dosing
Standard / Gradual Approach (2 mL = 10 mg/mL)
| Week | Daily Dose (μg) | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–2 | 10 μg (0.01 mg) | 0.1 units (0.001 mL) |
| Weeks 3–4 | 20 μg (0.02 mg) | 0.2 units (0.002 mL) |
| Weeks 5–6 | 50 μg (0.05 mg) | 0.5 units (0.005 mL) |
| Weeks 7–8 | 100 μg (0.1 mg) | 1 unit (0.01 mL) |
| Weeks 9–16 | 100–150 μg (0.1–0.15 mg) | 1–1.5 units (0.01–0.015 mL) |
Frequency: Inject once daily subcutaneously. Because all per-administration volumes are ≤1.5 units (≤0.015 mL), use 30-unit or 50-unit insulin syringes for improved readability and accuracy. Titrate slowly by adding 10–20 μg (0.1–0.2 units) every 1–2 weeks as tolerated[3].
Reconstitution Steps
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Supplies Needed
Plan based on a 16-week daily protocol with gradual titration. One 20 mg vial provides approximately 13,510 μg total usage over 16 weeks, so a single vial is sufficient for the full course.
- 16 weeks: 1 vial (with excess remaining)
- Per week: 7 syringes (1/day)
- 16 weeks: 112 syringes (recommend ~120 with extras)
- 16 weeks (1 vial): 2 mL → 1 × 10 mL bottle
- Per week: 14 swabs (2/day)
- 16 weeks: 224 swabs → recommend 3 × 100-count boxes
Protocol Overview
Concise summary of the once-daily regimen.